Reconsidering biologic treatment recommendations for CRSwNP without asthma in EUFOREA guidelines

View at publisher Summarise with VIRAT
Authors: John J Oppenheimer, G W Canonica, Pascal Chanez, Juan Manuel Maza-Solano, C Tacon, Konstantina Kallinikou, Peter Hugo Howarth, Matteo Bonini, Ibon Eguíluz‐Gracia, ARNAUD AB BOURDIN
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

The recently published EUFOREA pocket guide "Biologics in Upper and Lower Airway Diseases" summarises recommendations on the use of biologics in chronic rhinosinusitis with nasal polyps (CRSwNP) and asthma and offers advice on biologic choice for practicing clinicians. The creation of this pocket guide, in the absence of any head-to-head studies at that time, drew on expert opinions and published indirect treatment comparison (ITC) approaches. It makes a single recommendation for a preferred biologic, in patients affected by CRSwNP, without concomitant asthma (apart from specific cases such as pregnancy), whilst offering different options in asthma endotypes and phenotypes. We wish to draw the attention of the readership to some additional considerations relating to biologic choice for these diseases and how they are classified.

Fields of Study & Subjects

Sinusitis and nasal conditions Cystic Fibrosis Research Advances Asthma and respiratory diseases

Publication details

Journal / source
Rhinology Journal
Volume
0
Issue
0
Publication date
1 March 2026
Language
EN